This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Vishwesh Pravinchandra Pandya: Innovator in Pharmaceutical Chemistry
Introduction
Vishwesh Pravinchandra Pandya is a notable inventor based in Jamnagar, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of intermediates for HMG-CoA reductase inhibitors. His work has implications for the treatment of various health conditions, showcasing his innovative spirit and dedication to advancing medical science.
Latest Patents
Vishwesh holds a patent for "Intermediates for the preparation of HMG-CoA reductase inhibitors." This invention provides a process for preparing novel intermediates of a specific formula, where R can be hydrogen, C-Calkyl, halogen, nitro, hydroxy, or C-Calkoxy. The patent also details that R can be selected from the hydrophobic residue of HMG-CoA reductase inhibitors. These intermediates can be effectively used for the preparation of HMG-CoA reductase inhibitors such as rosuvastatin and pharmaceutically acceptable salts thereof. He has 1 patent to his name.
Career Highlights
Vishwesh is currently employed at Ranbaxy Laboratories, Inc., where he continues to contribute to pharmaceutical research and development. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Prabhakar Divya and Neera Tewari. Their collective expertise enhances the innovative environment at Ranbaxy Laboratories, Inc.
Conclusion
Vishwesh Pravinchandra Pandya is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact healthcare significantly. His innovative contributions, particularly in the development of HMG-CoA reductase inhibitors, highlight his role as a key player in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
